22:
135:
Initially the institute was founded to combat infectious diseases and to make and distribute serum preparations and vaccines. The early organisations were the State Serum
Laboratory (1911–1947; provisional 1911–1914), the State Serum Institute (1947–1970) and the Public Health Laboratory (1970–1981).
204:
External funding covered approximately 40% of all of the
Institute's costs. The most important funding agencies included the Academy of Finland, National Institutes of Health (USA), and the Framework Programs of the European Commission. KTL's policy was to secure as much external funding as possible
205:
to guarantee the implementation of its action plans. KTL also did research with private funds in the fields of vaccines and nutrition. Private funding has drawn criticism from some NGOs. On the other hand, the
Government and funding agencies have recommended increased collaboration with companies.
136:
The new Act in 1982 paved way for its transformation from a practical microbiological and clinical chemistry laboratory towards a research institute specializing in public health and prevention of diseases. This development was also seen in the organisation structure; new departments in
430:
Working group appointed by the
Academy of Finland, 2005: Long-term and dynamic partnerships. Research co-operation and researcher training between universities, research institutes and business companies.
196:'s group. KTL ranked very high among the Finnish research institutes, and was evaluated to do highly competitive and internationally relevant research. Complete lists of publications are available.
444:
A. S. Härö and V. Raunio: Seerumit aseina - vastustajina mikrobit (Sera as weapons against microbes); History of
National Public Health Institute and its predecessors. Helsinki 1990 (in Finnish).
238:
A. S. Härö and V. Raunio: Seerumit aseina - vastustajina mikrobit (Sera as weapons against microbes); History of
National Public Health Institute and its predecessors. Helsinki 1990 (in Finnish).
120:
148:
was complete, and the
Institute had few routine tasks. It served the government as an expert organisation, performing internationally relevant research related to public health.
116:
and prevent disease. KTL performed research in public health in broad sense, and monitored diseases. KTL also acquired and distributed the vaccines paid by the government.
119:
KTL was merged on 1 January 2009 with STAKES, the
National Research and Development Centre for Welfare and Health, to form a new research and development institute, the
419:
Breastfeeding
Support Association in Finland: Informed consent missing in infant formula study in Finland - public health policy issues regarding commercial interests
478:
214:
483:
279:
176:
produced internationally well-known results in preventing cardiovascular diseases. Later several environmental health projects mostly funded by the
102:
328:"The Health Protection Act, national guidelines for indoor air quality and development of the national indoor air programs in Finland"
219:
181:
65:
43:
370:
144:(originally Toxicology and Environmental Hygiene) were founded. In less than 10 years the transformation led by director general
165:
395:
109:. KTL was founded in 1911; the final form was established in 1982 in order to promote public health in Finland.
36:
30:
448:
192:. Finally, mainly in 1990s, genes involved in Finnish heritage of diseases were successfully identified in
429:
193:
47:
283:
169:
168:
to promote vaccination programs in developing countries. In epidemiology and health promotion so called
189:
185:
141:
256:
177:
406:
353:
343:
335:
267:
94:
86:
348:
327:
145:
472:
418:
137:
371:
Evaluation of the
National Public Health Institute of Finland -Kansanterveyslaitos
173:
157:
124:
314:
357:
339:
449:
https://web.archive.org/web/20110809061823/http://www.thl.fi/en_US/web/en/
462:
International Association of National Public Health Institutes (IANPHI)
382:
161:
106:
396:
GOOD RESEARCH PRACTICE IN THE NATIONAL PUBLIC HEALTH INSTITUTE B4/2006
113:
247:
Act on the National Public Health Institute 828/1982, section 1
15:
407:
http://www.rokotusinfo.fi/yhd/tiedotteet/tiedote_050601_html
105:
charged with the task of protecting and promoting health in
303:
461:
127:, who was also appointed Director General of the THL.
164:
by Pirjo Mäkelä's group, and collaboration with the
156:Top quality research at KTL included early work on
101:) was a research and expert institute under the
160:by Kari Cantell, research on several bacterial
79:The National Public Health Institute of Finland
180:added to international understanding of toxic
8:
215:BCG disease outbreak in Finland in the 2000s
123:(THL). The last Director General of KTL was
347:
121:National Institute for Health and Welfare
66:Learn how and when to remove this message
29:This article includes a list of general
231:
479:Medical research institutes in Finland
112:The institution had a duty to promote
103:Ministry of Social Affairs and Health
7:
188:as well as health problems due to
35:it lacks sufficient corresponding
14:
484:Public health research institutes
220:National public health institutes
20:
1:
152:Highlights of research at KTL
500:
383:"Kansanterveyslaitos KTL"
166:World Health Organization
451:with links to KTL pages
332:Environ Health Perspect
280:"North Karelia Project"
186:fine particulate matter
50:more precise citations.
340:10.1289/ehp.99107s3515
334:. 107 Suppl 3: 515–7.
194:Leena Peltonen-Palotie
98:
90:
184:in food, and outdoor
170:North Karelia Project
142:Environmental Health
178:European Commission
99:Folkhälsoinstitutet
91:Kansanterveyslaitos
326:Husman TM (1999).
76:
75:
68:
491:
432:
427:
421:
416:
410:
404:
398:
393:
387:
386:
379:
373:
368:
362:
361:
351:
323:
317:
312:
306:
301:
295:
294:
292:
291:
282:. Archived from
276:
270:
265:
259:
254:
248:
245:
239:
236:
200:External funding
71:
64:
60:
57:
51:
46:this article by
37:inline citations
24:
23:
16:
499:
498:
494:
493:
492:
490:
489:
488:
469:
468:
458:
441:
436:
435:
428:
424:
417:
413:
405:
401:
394:
390:
381:
380:
376:
369:
365:
325:
324:
320:
313:
309:
302:
298:
289:
287:
278:
277:
273:
266:
262:
255:
251:
246:
242:
237:
233:
228:
211:
202:
154:
133:
72:
61:
55:
52:
42:Please help to
41:
25:
21:
12:
11:
5:
497:
495:
487:
486:
481:
471:
470:
465:
464:
457:
456:External links
454:
453:
452:
447:THL home page
445:
440:
437:
434:
433:
422:
411:
399:
388:
374:
363:
318:
307:
296:
271:
260:
249:
240:
230:
229:
227:
224:
223:
222:
217:
210:
207:
201:
198:
153:
150:
146:Jussi Huttunen
132:
129:
74:
73:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
496:
485:
482:
480:
477:
476:
474:
467:
463:
460:
459:
455:
450:
446:
443:
442:
438:
431:
426:
423:
420:
415:
412:
408:
403:
400:
397:
392:
389:
384:
378:
375:
372:
367:
364:
359:
355:
350:
345:
341:
337:
333:
329:
322:
319:
316:
311:
308:
305:
300:
297:
286:on 2014-07-15
285:
281:
275:
272:
269:
264:
261:
258:
253:
250:
244:
241:
235:
232:
225:
221:
218:
216:
213:
212:
208:
206:
199:
197:
195:
191:
187:
183:
179:
175:
171:
167:
163:
159:
151:
149:
147:
143:
139:
130:
128:
126:
122:
117:
115:
110:
108:
104:
100:
96:
92:
88:
84:
80:
70:
67:
59:
49:
45:
39:
38:
32:
27:
18:
17:
466:
425:
414:
409:(in Finnish)
402:
391:
377:
366:
331:
321:
310:
299:
288:. Retrieved
284:the original
274:
263:
252:
243:
234:
203:
155:
138:Epidemiology
134:
118:
111:
82:
78:
77:
62:
56:October 2021
53:
34:
174:Pekka Puska
158:interferons
125:Pekka Puska
48:introducing
473:Categories
290:2011-08-12
226:References
190:indoor air
31:references
358:10347001
315:Expolis
209:See also
162:vaccines
439:Sources
349:1566220
304:Dioxins
257:Cantell
182:dioxins
172:led by
131:History
107:Finland
95:Swedish
87:Finnish
44:improve
356:
346:
268:Mäkelä
114:health
33:, but
354:PMID
140:and
344:PMC
336:doi
83:KTL
475::
352:.
342:.
330:.
97::
93:,
89::
85:,
385:.
360:.
338::
293:.
81:(
69:)
63:(
58:)
54:(
40:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.